NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Feb 26 2021

· Issued by NATCO Pharma Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

NATCO Pharma Limited has issued a press release announcing the launch of Brivaracetam tablets in India for the treatment of epilepsy. The tablets will be marketed under the brand name BRECITA and will be available in two strengths at lower prices compared to existing options.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

NATCO Pharma Limited on 6ix

Earlier from NATCO Pharma

Later from NATCO Pharma

All NATCO Pharma news releases